TY  - GEN
AU  - Bueno, Maria Jose
AU  - Mouron, Silvana
AU  - Caleiras, Eduardo
AU  - Martínez, Mario
AU  - Manso, Luis
AU  - Colomer, Ramón
AU  - Quintela-Fandino, Miguel
PY  - 2024
DO  - 10.1007/s12094-023-03329-9
UR  - https://hdl.handle.net/20.500.12105/23122
AB  - BACKGROUND: HER2, TROP2 and PD-L1 are novel targets in triple-negative breast cancer (TNBC). The combined expression status of these targets, and whether they can define prognostic subgroups, is currently undefined. METHODS: Immunohistochemistry was...
LA  - eng
PB  - Springer
KW  - Triple Negative Breast Neoplasms
KW  - Bridged-Ring Compounds
KW  - Taxoids
KW  - Humans
KW  - Carboplatin
KW  - B7-H1 Antigen
KW  - Anthracyclines
KW  - Antibiotics, Antineoplastic
KW  - Neoadjuvant Therapy
KW  - Antineoplastic Combined Chemotherapy Protocols
TI  - Distribution of PD-L1, TROP2 and HER2- "lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalation
TY  - research article
ER  -